Vyant Bio, Inc. (OTCMKTS:VYNT – Get Free Report)’s stock price shot up 7.8% during trading on Friday . The company traded as high as $0.20 and last traded at $0.19. 19,100 shares were traded during mid-day trading, a decline of 88% from the average session volume of 161,822 shares. The stock had previously closed at $0.18.
Vyant Bio Price Performance
The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 0.04. The firm’s 50 day moving average price is $0.19 and its two-hundred day moving average price is $0.19.
About Vyant Bio
Vyant Bio, Inc, a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD).
Recommended Stories
- Five stocks we like better than Vyant Bio
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Why Invest in 5G? How to Invest in 5G Stocks
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Buy P&G Now, Before It Sets A New All-Time High
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Vyant Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vyant Bio and related companies with MarketBeat.com's FREE daily email newsletter.
